ArticleBMC cancer2025

Identification of HOXA9 methylation as an epigenetic biomarker predicting prognosis and guiding treatment choice in acute myeloid leukemia.

Fei Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.